Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Iot crawled time : 20:20 save search
IOT LOSS ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Samsara Inc. Investors to Inquire About Securities Class Action Investigation - IOT
Published: 2023-09-30 (Crawled : 20:20) - prnewswire.com
LYV | $90.33 0.77% 220K
|
Consumer Services
| Email alert
Add to watchlist
IOT S | $30.25 -2.45% 340K
|
n/a
| Email alert
Add to watchlist
DFS | $124.19 -0.06% 340K
|
Finance
| Email alert
Add to watchlist
iot global
5G IoT Market Report 2022: Sector to Reach $17.68 Billion by 2030 at a CAGR of 47.6%
Published: 2023-01-22 (Crawled : 20:20) - prnewswire.com
ZTCOF | $1.91 200
|
Electronic Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
NOKBF | News | $3.38 1.5K
|
Electronic Technology
|
| O: 0.0%
H: 2.16%
C: 0.76%
VZ | News A | $40.345 0.54% 4.7M
|
Communications
|
| O: -0.02%
H: 0.88%
C: -0.9%
NOK | News | $3.515 1.88% 5M
|
Electronic Technology
|
| O: 0.22%
H: 1.08%
C: 0.22%
T | $16.33 10M
|
Communications
|
| O: 0.0%
H: 0.88%
C: -0.68%
QCOM | $160.35 -0.68% 1.4M
|
Electronic Technology
|
| O: 2.96%
H: 4.36%
C: 3.55%
INTC | News | $34.835 -0.59% 15M
|
Electronic Technology
|
| O: 0.36%
H: 3.97%
C: 3.22%
ERIC | News | $5.12 1.19% 5.9M
|
Electronic Technology
|
| O: 2.82%
H: 1.2%
C: 0.0%
report iot market
Fortress Biotech Reports First Quarter 2021 Financial Results and Recent Corporate Highlights
Published: 2021-05-16 (Crawled : 20:20) - globenewswire.com
MBIO | $0.371 10K
|
Health Technology
|
| O: -0.72%
H: 4.98%
C: 3.25%
FBIO | $1.765 -2.49% 90K
|
Health Technology
|
| O: -1.9%
H: 0.37%
C: -1.94%
CKPT | $1.62 1.25% 120K
|
Health Technology
|
| O: 0.84%
H: 3.55%
C: 1.67%
financial results results biotech iot
ImmunoPrecise To Participate in BiotechGate Digital Partnering Event
Published: 2021-05-02 (Crawled : 20:20) - immunoprecise.com
IPA | $1.24 3.4K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
biotech iot
Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-experienced Wet AMD Patients at ARVO 2021
Published: 2021-05-01 (Crawled : 20:20) - globenewswire.com
ADVM | $11.175 0.22% 2.1K
|
Health Technology
| Email alert
Add to watchlist
treatment gene therapy therapy biotech iot trial dmd gene therapies
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
PRTG | $0.285 18.75% 170K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.